Last reviewed · How we verify

NCT07419399: RDPP

Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis

Recruiting now NA Last updated 19 February 2026
What this trial tests

NA trial testing Radiofrequency diathermy (RFD) in Postpartum in 48 participants. Currently enrolling.

Timeline
30 March 2026
Primary endpoint
30 March 2029
30 March 2029

Quick facts

Lead sponsorUniversity of Valencia
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment48
Start date30 March 2026
Primary completion30 March 2029
Estimated completion30 March 2029
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Valencia

Who can join

Adults 20 to 45, female only, with Postpartum or Rectus Muscle Diastasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial aims to compare the immediate tissue response in postpartum women with and without rectus abdominis diastasis (RAD) after undergoing radiofrequency diathermy (RFD) treatment. The main question it seeks to answer is: Do postpartum women with and without RAD exhibit different acute tissue responses in terms of pressure pain threshold, superficial thermal sensitivity, and tissue elasticity? To determine whether there are differences in these acute tissue responses between the groups, researchers will compare RFD with a sham RFD intervention in postpartum women with and without RAD. Participants will receive one session of either RFD or a sham RFD intervention and will complete three assessments: one at baseline and two after the intervention, one immediately afterwards and one 20 minutes afterwards.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postpartum

Currently open trials in the same condition.

Other University of Valencia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07419399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing